Literature DB >> 3531514

Trial of (+)-cyanidanol-3 in patients with hepatitis B chronic liver disease.

P W Keeling, L Viola, M G Anderson, J H Marigold, J C Macartney, F J Paradinas, I M Murray-Lyon, R P Thompson.   

Abstract

A double-blind controlled trial of 12 months' treatment with (+)-cyanidanol-3 was carried out in 26 patients with chronic hepatitis B liver disease. Treatment did not improve liver blood tests nor histological appearances of the liver, but there was a trend towards reduction of serum titres of hepatitis B surface antigen.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3531514      PMCID： PMC1290416          DOI： 10.1177/014107688607900809

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


  6 in total

1.  Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.

Authors:  S Bar-Meir; Z Halpern; M Gutman; Z Shpirer; M Baratz; D Bass
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

2.  Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B.

Authors:  S W Schalm; R A Heytink; H R van Buuren; R A de Man
Journal:  Lancet       Date:  1985-08-17       Impact factor: 79.321

3.  Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe.

Authors:  E Sagnelli; F Piccinino; G Manzillo; F M Felaco; P Filippini; G Maio; G Pasquale; C M Izzo
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

4.  Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).

Authors:  A Pár; M Paál; I Kádas; E Kerekes; T Jávor
Journal:  Acta Med Hung       Date:  1983

5.  (+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial.

Authors:  H Schomerus; K H Wiedmann; W Dölle; H Peerenboom; G Strohmeyer; K Balzer; H Goebell; H K Dürr; C Bode; A L Blum
Journal:  Hepatology       Date:  1984 Mar-Apr       Impact factor: 17.425

6.  Treatment of acute viral hepatitis with (+)-cyanidanol-3.

Authors:  A L Blum; P Berthet; W Doelle; H Goebell; K Kortüm; S Pelloni; P Peter; H Poulsen; G Strohmeyer; N Tygstrup
Journal:  Lancet       Date:  1977-12-03       Impact factor: 79.321
  6 in total
  1 in total

1.  Drugs effects on superoxide generation and chemiluminescence response of human leukocytes.

Authors:  C Pascual; R González; C Romay
Journal:  Agents Actions       Date:  1991-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.